Autotaxin inhibitor compound 1
(Autotaxin-IN-1) manufacturers
- Autotaxin-IN-1
-
- $1670.00
-
2026-05-11
- CAS:1619971-30-0
- Purity:
- Supply Ability: 10g
- Autotaxin-IN-1
-
- $1670.00
-
2025-08-22
- CAS:1619971-30-0
- Purity:
- Supply Ability: 10g
|
| | Autotaxin inhibitor compound 1
(Autotaxin-IN-1) Basic information |
| Product Name: | Autotaxin inhibitor compound 1
(Autotaxin-IN-1) | | Synonyms: | Autotaxin inhibitor compound 1
(Autotaxin-IN-1);Autotaxin-IN-1;Autotaxin inhibitor compound 1;Ethanone, 1-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl]-2-[2-(1H-1,2,3-triazol-5-yl)ethoxy]-;AutotaxinIN1,Autotaxin IN 1 | | CAS: | 1619971-30-0 | | MF: | C21H23N7O2 | | MW: | 405.45 | | EINECS: | | | Product Categories: | | | Mol File: | 1619971-30-0.mol |  |
| | Autotaxin inhibitor compound 1
(Autotaxin-IN-1) Chemical Properties |
| | Autotaxin inhibitor compound 1
(Autotaxin-IN-1) Usage And Synthesis |
| Description | Autotaxin-IN-1 is a potent inhibitor of autotaxin. | | Uses | Autotaxin-IN-1 is a potent autotaxin inhibitor, which has favorable potency (IC50=2.2 nM), PK properties, and a robust PK/PD relationship. Autotaxin-IN-1 is used in treatment of osteoarthritis pain[1]. | | in vivo | Autotaxin-IN-1 (i.v.; 1.0mg/kg) has T1/2 of 1.14 hours[1].
Autotaxin-IN-1 (p.o.; 10 mg/kg) has Cmax of 660 nM and AUC of 3440 nM h[1]. | Animal Model: | Normal rat[1] | | Dosage: | 1.0 mg/kg, 10 mg/kg (Pharmacokinetic Study) | | Administration: | I.v. (1.0 mg/kg); p.o. (10 mg/kg) | | Result: | Has T1/2 of 1.14 hours (i.v.; 1.0mg/kg).
Has Cmax of 660 nM and AUC of 3440 nMh (p.o.; 10 mg/kg).
|
| | IC 50 | Autotaxin: 2 nM (IC50) | | References | [1] Jones SB, et al. Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design. ACS Med Chem Lett. 2016 Aug 2;7(9):857-61. DOI:10.1021/acsmedchemlett.6b00207 |
| | Autotaxin inhibitor compound 1
(Autotaxin-IN-1) Preparation Products And Raw materials |
|